within drug substance synthesis
play

within drug substance synthesis Dr Michael Burns Senior Scientist - PowerPoint PPT Presentation

Controlling a cohort Understanding the risk of nitrosamines within drug substance synthesis Dr Michael Burns Senior Scientist michael.burns@lhasalimited.org Outline Purge approach for nitrosamine risk assessments Exploring


  1. Controlling a cohort Understanding the risk of nitrosamines within drug substance synthesis Dr Michael Burns Senior Scientist michael.burns@lhasalimited.org

  2. Outline • Purge approach for nitrosamine risk assessments • Exploring potential reactivity of nitrosamines • Formation of N -nitroso compounds (NOCs)

  3. Purge approach for nitrosamine risk assessments

  4. Purge assessments and risk assessments • Industry were faced with a near insurmountable task to review all products within 6 months (March 2020). • Deadline was extended by 6 months to October 2020. • Batch testing for the presence of nitrosamines within all drug substances is problematic • Insufficient worldwide capacity for testing of appropriate sensitivity • In the short term identifying highest potential risk products is key. • Industry group EFPIA have been working to establish a workflow to address this issue. • EFPIA and EMA are engaging to get to a point of agreement. • If there are no nitrosating agents or secondary/tertiary amines present within the synthetic route (as reagents or by-products) then risk is deemed low/non-existent.

  5. What if there is a potential risk? • If amines and nitrosating agents are present, then a risk does exist, but not all risks are high. • Both components must be present at high enough levels within the same step to create a significant risk of formation. • Where present together, conditions must be conducive to nitrosamine formation (e.g. acidic conditions) • Purge assessments can be used in two ways to determine the risk in line with ICH M7 control options. • Is there a genuine risk of nitrosamine formation? • Will potential nitrosamines persist into the API?

  6. De-risking Candesartan (AZ) • Candesartan is a drug marketed by AZ • Risk is present from potential amines resulting from triethylamine and DMF degradation. • Purge assessment of these impurities indicates there is no realistic possibility of NaNO 2 being present in the same stage as an amine. • Even if formed, a reasonable potential to purge also exists in the subsequent stages.

  7. Understanding purge In-depth understanding of the process conditions is vital, as this allows appropriate use of purge values.

  8. Purge Ratio • The use of the purge ratio (PR) has been widely adopted to define the regulatory reporting expectations for purge calculations, with further conservatism built in. • E.g. Where PR > 1000 - very little support is required to back up an option 4 approach • How can the purge ratio be utilised within the nitrosamine risk assessment? 8 Barber et al, Regul. Toxicol. Pharmacol., 2017, 90, 22-28

  9. Utilising Purge Ratio • Nitrosamine risk is only present if they can be formed in sufficient quantities to exceed permissible levels. • Principles of the purge ratio can be applied to the components required to generate a nitrosamine to act as a guide to the risk of formation at a concerning level Predicted Purge Predicted Purge Purge Ratio Purge Ratio Purge Ratio (1 ppm limit) (1 ppm limit) (30 ppb limit*) 8.1 × 10 8 8.1 × 10 8 Triethyl amine Triethyl amine 16200 16200 486 7.3 × 10 9 7.3 × 10 9 DMF DMF 36500 36500 1095 * Assumes quantitative conversion of the amine precursor into a nitrosamine, in itself highly unlikely. Linked to control limits for Sartans in Article 31

  10. De-risking Candesartan (AZ) Initially • > 40 batches of API tested – NDMA not detected (LoD 150 ppb) • DMA not detected in Stage 5 (LoD 100 ppb) • Nitrite not detected after Stage 5 Now • Option 4 backed up by testing • >85 batch analyses for NDMA and NDEA (LoD 5 ppb) • >65 batches tested for 5 nitrosamines This work has now been published: Org. Process Res. Dev. Just Accepted Manuscript , doi.org/10.1021/acs.oprd.0c00264

  11. Exploring potential reactivity of nitrosamines

  12. Nitrosamines: structure and overall reactivity Russ. Chem. Rev. 1971 , 40 , 34-50 The chemistry of Amino, Nitroso and Nitro compounds and their derivative 1982, 1151-1223.

  13. Nitrosamine Reduction • Knowledge of reactivity of nitrosamines under the following conditions: • LiAlH 4 Strongest evidence of purge • Zn, Acid (HCl, AcOH) • H 2 , RaNi • SnCl 2 Evidence of purge – but limited quantity • NaBH 4 , Lewis acid • H 2 , Pd/Pt Variable purge – highly dependant on • conditions and/or competition DIBAL

  14. Nitrosamine Reduction LiAlH4 Zn/aqueous acid Fe/aqueous acid H2/metal catalyst NaBH4/Lewis acid 0 20 40 60 80 100 120 140 Number of reported yields for reducing agents o Readily reduced - strong hydrides, zinc or iron in aqueous acid. o Readily reduced by Raney nickel. o Can be reduced by sodium borohydride with the addition of a Lewis acid (e.g. NiCl 2 , TiCl 4 ). o Moderate reactivity with DIBAL. o No evidence of reduction by boranes (i.e. BH 3 ), although C -nitroso compounds are reduced.

  15. Nitrosamine Reduction WO2019236710A1 WO2003106457A1

  16. Nitrosamine Reduction • <100 results with reported yields • Majority use Raney nickel • RT, alcohol solvents and short reaction times • Amine is the main product • Reactivity is catalyst and condition dependent Synthesis 1976 , 548-550

  17. Nitrosamine Reduction: Raney Nickel J. Am. Chem. Soc. 2013 , 135 , 468-473 Synthesis 1976 , 548-550 J. Org. Chem. 1986, 51, 14, 2687-2694

  18. Nitrosamine Reduction: Palladium Tetrahedron 1997 , 38 , 619-620 J. Antibiot. 1993 , 46 , 1716-1719 J. Chem. Soc., Perkin Trans. 1 , 1990 , 3103-3108

  19. Nitrosamine Reduction: Platinum J Med Chem 1984 , 27 , 1710 - 1717 Helv. Chim. Acta 1980 , 63 , 2554-2558

  20. Nitrosamine Oxidation • Oxidations of nitrosamines have limited public data available. • Knowledge of reactivity of nitrosamines under the following conditions: • H 2 O 2 + AcOH/TFA Strongest evidence of purge • H 2 O 2 • KMnO 4 • MnO 2 Available evidence suggests limited purge • Chromium Oxidants • DMP • mCPBA/DMDO • Ozone, oxone, Swern No data available

  21. Nitrosamine Oxidation Majority of evidence of oxidation to nitramines is with peroxide reagents: Synthesis, 1985, 1985, 677-679 US20090286994A1 J. Am. Chem. Soc., 1954, 76, 3468-3470

  22. Nitrosamine Oxidation Limited evidence of nitrosamine oxidation with inorganic reagents: Org. Lett. , 2017, 19, 894-897 Ber. Dtsch. Chem. Ges ., 1901, 34, 1642-1646 Chem Res Tox. , 2000, 13, 72-81 Org. Lett. , 2017, 19, 894-897

  23. Nitrosamine Denitrosation HCl TFA H2SO4 HOAC HCl/CuCl chlorosulfonyl isocyanate HClO4 0 20 40 60 80 100 120 140 160 180 200 Number of examples with reported yields • Normally carried out with aqueous acids (e.g. HCl, TFA, H 2 SO 4 , AcOH, HBr) • Alternative methods have been reported: CuCl/HCl, BF 3 • THF/NaHCO 3 (aq), chlorosulphonyl isocyanate

  24. Nitrosamine Denitrosation Syn. Commun. 2015 , 45 , 2030-2034 Org. Biomol. Chem. 2014 , 12 , 8390-8393 • The equilibrium is dependent on the acid, nitrosamine and temperature. • Hydrolysis normally occurs in aqueous acid at pH < 3 • HCl (0.5 – 5 M) and H 2 SO 4 (50 – 80%) are two most commonly used acids. • HCl and HBr are very efficient as the halide nucleophile can facilitate amine release. • Removal of the amine or NOX from the reaction is necessary for complete reaction. • Typical NOX ‘traps’ are: NaN 3 , HN 3 , urea, sulphamic acid, hydrazine, MeOH, EtOH.

  25. Nitrosamines and Organometallics Grignard reagents: Nitroso nitrogen alkylation followed by α -carbon alkylation with excess Grignard reagent to form trisubstituted hydrazines. Farina PR et al., J. Org. Chem., 1975, 40, 1070-1074

  26. Nitrosamines and Organometallics Organozinc reagents: Grignard reagents: Nitroso nitrogen alkylation followed by α -carbon alkylation with Violent reaction with diethylzinc: excess Grignard reagent to form trisubstituted hydrazines. Lachman A, Am. Chem. J., 1899, 21, 433-446 No reaction with diethylzinc: Farina PR et al., J. Org. Chem., 1975, 40, 1070-1074

  27. Nitrosamines and Organometallics Organolithium reagents: Nitroso nitrogen alkylation, followed by dimerization to form hexahydrotetrazines. Farina PR et al., J. Org. Chem., 1973, 38, 4259-4263 Nitroso nitrogen alkylation, followed by α -carbon alkylation to form trialkylhydrazines. Vazquez AJ et al., Synth. Commun., 2009, 39, 3958-3972

  28. Summary There is limited good quality data in the literature for nitrosamine reactivity – only 4 main transformations. • Reduction is highly dependant on the reductant: • Oxidation is highly dependant on the oxidant: • Hydrogen peroxide Lithium aluminium tetrahydride • Zinc or iron in acid Hydrogen peroxide and acetic acid/trifluoroacetic acid • Hydrogen with Raney nickel • Denitrosation by acid hydrolysis requires relatively high acid concentrations and a trap . • Organometallic addition can occur, but data is limited. • There are significant areas that need further experimental investigation: • Hydrogenation catalyst/conditions • Inorganic oxidising agents

  29. Formation of N -nitroso compounds (NOCs)

  30. Classical Nitrosamine Formation • NOC formation is dominated by N -nitrosation of a NH-containing compound with a nitrosating agent • amine (secondary/tertiary) • (hetero)amide • Carbamate • hydroxylamine • hydrazine Reactive [NO] + carriers: 6 main species • [NO] + precursors: numerous reagents •

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend